Search
12 result(s) for 'author#Avner Reshef' within BMC
Page 1 of 1
Sort by: Relevance | Date
-
Citation: Allergy, Asthma & Clinical Immunology 2017 13(Suppl 2):29
-
Abstracts of 11th C1-inhibitor Deficiency & Angioedema Workshop
Citation: Allergy, Asthma & Clinical Immunology 2019 15(Suppl 4):45 -
Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions
Citation: World Allergy Organization Journal 2014 7:47 -
Reviewer acknowledgement 2015
The editors of World Allergy Organization Journal would like to thank all of our reviewers who have contributed to the journal in Volume 8 (2015).
Citation: World Allergy Organization Journal 2016 9:6 -
WAO International Scientific Conference (WISC 2016) Abstracts
Citation: World Allergy Organization Journal 2017 10(Suppl 1):25 -
Abstracts of the XXII World Allergy Congress, 4-8 December, 2011 Cancún, México
Citation: World Allergy Organization Journal 2012 5(Suppl 2):275 -
WAO Guideline for the Management of Hereditary Angioedema
Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and appropriate therapy are often unknown or not available for physicians and other health care providers. For this reason we ...
Citation: World Allergy Organization Journal 2012 5:33 -
5th Pediatric Allergy and Asthma Meeting (PAAM)
Citation: Clinical and Translational Allergy 2018 8(Suppl 2):26 -
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angio...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:24 -
HAE international home therapy consensus document
Hereditary angioedema (C1 inhibitor deficiency, HAE) is associated with intermittent swellings which are disabling and may be fatal. Effective treatments are available and these are most useful when given earl...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:22 -
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
Women with hereditary angioedema due to C1-inhibitor deficiency (HAE-C1INH) experience more frequent and severe angioedema attacks compared with men. Fluctuations in female sex hormones can influence HAE attac...
Citation: Allergy, Asthma & Clinical Immunology 2020 16:8 -
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update
Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate therapy are essential. This update and revision of the global guideline for HAE provides up-to-date consensus recomm...
Citation: World Allergy Organization Journal 2018 11:5